Rob Stewart Archives - CDR – Chain Drug Review

Amneal among companies to launch generic version of Lyrica

July 22, 2019 by Chain Drug Review Alembic, Alkem, Amneal Pharmaceuticals, Dr. Reddy’s, generic version of Lyrica, InvaGen, MSN Laboratories, pregabalin capsules, Rising Pharmaceuticals, Rob Stewart, Sciegen, Teva Pharmacy, Supplier News

BRIDGEWATER, N.J. — The Food and Drug Administration has approved a number of applications for the generic version of Pfizer’s Lyrica (pregabalin). The FDA gave the green light to the following companies: Amneal, Alembic, Alkem, Dr. Reddy’s, InvaGen, MSN Laboratories, Rising Pharmaceuticals, Sciegen, and Teva. Amneal’s generic version of Lyrica (pregabalin capsules) will be available

Amneal announces restructuring and costs savings plan

July 11, 2019 by Chain Drug Review Amneal Pharmaceuticals, Rob Stewart Pharmacy, Supplier News

BRIDGEWATER, N.J. — Amneal Pharmaceuticals announced this week a comprehensive restructuring plan designed to reduce its cost base, further right size its organization and optimize its global manufacturing infrastructure. “Recently we initiated an in depth, company-wide review of our organizational structures, operational budgets, current and future capital projects, and existing capability and infrastructure alignments,” said